Factor IIa
12 drugs Cardiovascular
6
approved indications
12
Approved Drugs
4
Companies
8
Indications
1
Therapeutic Areas
Top Drugs
Unlock Full Target Intelligence PRO
✓ Competitive landscape by company (4 companies)
✓ All 12 approved drugs
✓ Therapeutic area breakdown
✓ Full indication list (8 indications)
✓ Patent cliff analysis
✓ Clinical trials pipeline
Upgrade to Pro
Starting at $99/mo
Drugs by Company
Pfizer 6 drugs
Fresenius Kabi 3 drugs
Baxter 2 drugs
By Therapeutic Area
Cardiovascular 8 drugs
Other 4 drugs
Drugs by Company PRO
Pfizer 6 drugs
HEPARIN SODIUM 1,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINERHEPARIN SODIUM 10,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINERHEPARIN SODIUM 12,500 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINERHEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINERHEPARIN SODIUM 2,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINERHEPARIN SODIUM 12,500 UNITS IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
Fresenius Kabi 3 drugs
Baxter 2 drugs
CORMEDIX 1 drug
By Therapeutic Area
Cardiovascular 8 drugs
HEPARIN SODIUM 1,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.45%, HEPARIN SODIUM IN PLASTIC CONTAINER, HEPARIN SODIUM 25,000 UNITS IN DEXTROSE 5% +4 more
Other 4 drugs
DEFENCATH, HEPARIN SODIUM 25,000 UNITS IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER, HEPARIN SODIUM 2,000 UNITS IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, HEPARIN SODIUM 12,500 UNITS IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
Indications Treated
Venous ThrombosisPulmonary EmbolismDeep Venous ThrombosisAtrial FibrillationDisseminated Intravascular CoagulationPeripheral Arterial EmbolismCatheter-Related Bloodstream InfectionKidney Failure